Event Calendar

Tuesday, August 3, 2021

NPA LTC Network - A Case for NUPLAZID

Start Date: 8/3/2021 5:00 PM CDT
End Date: 8/3/2021 6:00 PM CDT

Location:
United States 

Event Website: https://hwpnj.zoom.us/meeting/register/tJYqcO2vpzopEtN59szO6TPWFn2ydvSKZ-fy

Organization Name: Nebraska Pharmacists Association

Contact:
Caitlynn Lassek, PharmD, NPA LTC Network Chair
Email: classek@cpharmrx.com
Phone: (402) 420-1500

Register for A Long-Term Care Resident With Hallucinations and Delusions Associated With Parkinson's Disease Psychosis: A Case for NUPLAZID with guest speaker Kaylee Mehlman, PharmD, RPh, BCGP, FASCP, Principal Geramed Senior Care Consulting Lakewood, Ohio. Dr. Mehlman will address information about hallucinations and delusions associated with Parkinson's disease (PD) psychosis including:

  • What is PD psychosis?
  • Why does PD psychosis matter?
  • How to recognize PD psychosis in my residents with PD?
  • How to approach hallucinations and delusions associated with PD psychosis clinically?

Dr. Mehlman will review the clinical efficacy data and safety profile of NUPLAZID (pimavanserin) 34 mg, the first and only FDA-approved treatment for hallucinations and delusions associated with PD psychosis.

Space is limited. Register by July 30, 2021, using code 301417.